These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33618080)

  • 1. Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey.
    Lombardi A; Colaneri M; Sambo M; Di Matteo A; Sacchi P; Fabbiani M; Codecasa L; Aliberti S; Blasi F; Bandera A; Bruno R; Gori A
    Respir Med; 2021 Apr; 179():106341. PubMed ID: 33618080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.
    Wagner D; van Ingen J; van der Laan R; Obradovic M;
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32332023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.
    van Ingen J; Wagner D; Gallagher J; Morimoto K; Lange C; Haworth CS; Floto RA; Adjemian J; Prevots DR; Griffith DE;
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28182571
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical treatment of nontuberculous mycobacterial lung disease.
    Shiraishi Y
    Gen Thorac Cardiovasc Surg; 2014 Aug; 62(8):475-80. PubMed ID: 24740640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections with atypical mycobacteria in children].
    Heier I; Knudsen PK; Wathne KO
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):800-2. PubMed ID: 12693120
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis.
    Okamori S; Asakura T; Nishimura T; Tamizu E; Ishii M; Yoshida M; Fukano H; Hayashi Y; Fujita M; Hoshino Y; Betsuyaku T; Hasegawa N
    BMC Infect Dis; 2018 Jan; 18(1):1. PubMed ID: 29291713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nontuberculous mycobacterial lung infections].
    Chuard C; Erard V
    Rev Med Suisse; 2011 Oct; 7(312):1982-4, 1986-7. PubMed ID: 22097449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.
    Rammaert B; Couderc LJ; Rivaud E; Honderlick P; Zucman D; Mamzer MF; Cahen P; Bille E; Lecuit M; Lortholary O; Catherinot E
    BMC Infect Dis; 2011 Nov; 11():311. PubMed ID: 22054169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.
    Adjemian J; Prevots DR; Gallagher J; Heap K; Gupta R; Griffith D
    Ann Am Thorac Soc; 2014 Jan; 11(1):9-16. PubMed ID: 24236749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
    Ferrer M; Menendez R; Amaro R; Torres A
    Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation.
    Schildkraut JA; Gallagher J; Morimoto K; Lange C; Haworth C; Floto RA; Hoefsloot W; Griffith DE; Wagner D; Ingen JV;
    Respir Med; 2020 Nov; 173():106164. PubMed ID: 32992265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.
    Choi H; Jhun BW; Kim SY; Kim DH; Lee H; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):293-295. PubMed ID: 29329759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014.
    Ringshausen FC; Wagner D; de Roux A; Diel R; Hohmann D; Hickstein L; Welte T; Rademacher J
    Emerg Infect Dis; 2016 Jun; 22(6):1102-5. PubMed ID: 27191473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.
    Safdar A
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1883-7. PubMed ID: 22198679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.